Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis

Summary

A mass balance study to determine the routes and rates of elimination of radioactivity, to determine total radioactivity in plasma and whole blood over time and compare levels to JTZ-951 and drug-derived entities in plasma and to determine pharmacokinetic (PK) parameters of JTZ-951 and its metabolite(s).

Timeline

Start

2016-06

Primary completion

2016-09

Completion

2016-09

Drugs

Indications